HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance

HCA Healthcare, Inc.

2024-Q1 EPS reported $5.93 revenue$17,339,000,000

Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).
Adjusted EBITDA $3.353B; same facility admissions +6.2%, equivalent admissions +5.2%.
Cash from operations $2.469B; repurchased 3.894M shares for $1.180B; $5.595B remaining.
Board declared $0.66/share dividend, payable June 28 to holders of record June 14.
Reaffirmed 2024 guidance; includes $201M gain on sale of California hospital.

item 2.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HCA Healthcare, Inc. reported the first quarter ended March 31, 2024 results: revenue $17.339 billion, net income $1.591 billion, EPS $5.93 per diluted share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2024
Revenue: $17.339 billion
Net income: $1.591 billion
EPS: $5.93 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): ● Revenues totaled $17.339 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-115857

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.